Skip to content

FLORIDA / NEW YORK

561.316.3330

Facebook X-twitter Linkedin

Medical Device News Magazine

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

  • HOME
    • ABOUT
      • PRESS RELEASES
      • EDITORIAL
  • ADVERTISE
  • MEDICAL DEVICES
    • BIOTECHNOLOGY
    • CLINICAL TRIALS
  • INDUSTRY BYLINES
  • OTHER NEWS
    • EXECUTIVES
    • HOSPITALS
    • IMAGING
    • MERGERS/ACQUISITIONS
    • FUNDING
    • FDA
    • MARKET REPORTS
    • HEALTHCARE BUSINESS
    • HEALTHCARE PROFESSIONALS
    • CAREERS
  • HEALTH
    • ARTICLES
  • HOME
    • ABOUT
      • PRESS RELEASES
      • EDITORIAL
  • ADVERTISE
  • MEDICAL DEVICES
    • BIOTECHNOLOGY
    • CLINICAL TRIALS
  • INDUSTRY BYLINES
  • OTHER NEWS
    • EXECUTIVES
    • HOSPITALS
    • IMAGING
    • MERGERS/ACQUISITIONS
    • FUNDING
    • FDA
    • MARKET REPORTS
    • HEALTHCARE BUSINESS
    • HEALTHCARE PROFESSIONALS
    • CAREERS
  • HEALTH
    • ARTICLES

JelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program

  • Post author:Medical Device News Magazine
  • Post published:February 1, 2023
  • Post category:FUNDING

JelikaLite notes the pilot study data suggests that JelikaLite’s Cognilum medical device reduces symptoms of autism in young children and improves the quality of life of their families.

Continue ReadingJelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Contact Us Today!

  • Email: advmdn@infomeddnews.com
  • Florida | New York
  • HOME
    • ABOUT
  • ADVERTISE
  • PRIVACY STATEMENT
    • COOKIE POLICY
  • CONTACT
  • HOME
    • ABOUT
  • ADVERTISE
  • PRIVACY STATEMENT
    • COOKIE POLICY
  • CONTACT

Copyright 2025 | All Rights Reserved | Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.